118 related articles for article (PubMed ID: 2022343)
1. Theoretical studies on mechanism of MPTP action: ET interference by MPP+ (1-methyl-4-phenylpyridinium) with mitochondrial respiration vs. oxidative stress.
Kovacic P; Edwards WD; Ming G
Free Radic Res Commun; 1991; 14(1):25-32. PubMed ID: 2022343
[TBL] [Abstract][Full Text] [Related]
2. A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial function.
Walker MJ; Jenner P; Marsden CD
Biochem Pharmacol; 1991 Jul; 42(4):913-9. PubMed ID: 1651082
[TBL] [Abstract][Full Text] [Related]
3. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
[TBL] [Abstract][Full Text] [Related]
4. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
Vyas I; Heikkila RE; Nicklas WJ
J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone.
Krueger MJ; Singer TP; Casida JE; Ramsay RR
Biochem Biophys Res Commun; 1990 May; 169(1):123-8. PubMed ID: 2350337
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
Mizuno Y; Sone N; Saitoh T
J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
[TBL] [Abstract][Full Text] [Related]
8. Uptake of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the N-methyl-4-phenylpyridinium ion (MPP+) into fetal mouse brain through the placenta.
Ohya Y; Naoi M; Ochi N; Mizutani N; Watanabe K; Nagatsu T
Neurosci Lett; 1989 Oct; 105(1-2):221-6. PubMed ID: 2485882
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
10. MPTP, MPP+ and mitochondrial function.
Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
[TBL] [Abstract][Full Text] [Related]
11. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
Johannessen JN
Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of complex I by hydrophobic analogues of N-methyl-4-phenylpyridinium (MPP+) and the use of an ion-selective electrode to measure their accumulation by mitochondria and electron-transport particles.
Murphy MP; Krueger MJ; Sablin SO; Ramsay RR; Singer TP
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):359-65. PubMed ID: 7887889
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-L-carnitine cytoprotection against 1-methyl-4-phenylpyridinium toxicity in neuroblastoma cells.
Mazzio E; Yoon KJ; Soliman KF
Biochem Pharmacol; 2003 Jul; 66(2):297-306. PubMed ID: 12826272
[TBL] [Abstract][Full Text] [Related]
15. Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.
Schildknecht S; Pape R; Meiser J; Karreman C; Strittmatter T; Odermatt M; Cirri E; Friemel A; Ringwald M; Pasquarelli N; Ferger B; Brunner T; Marx A; Möller HM; Hiller K; Leist M
Antioxid Redox Signal; 2015 Nov; 23(13):1001-16. PubMed ID: 26413876
[TBL] [Abstract][Full Text] [Related]
16. [Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].
Mizuno Y
Rinsho Shinkeigaku; 1989 Dec; 29(12):1494-6. PubMed ID: 2698296
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver.
Thakar JH; Hassan MN; Grimes JD
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):355-62. PubMed ID: 3260387
[TBL] [Abstract][Full Text] [Related]
18. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
Glia; 1992; 5(1):48-55. PubMed ID: 1311704
[TBL] [Abstract][Full Text] [Related]
19. The relative abilities of MPTP and MPP+ to compete with [3H]dopamine for the rat and marmoset striatal dopamine uptake site.
Barnes NM; Cheng CH; Costall B; Naylor RJ
Biochem Pharmacol; 1990 Feb; 39(4):809-11. PubMed ID: 2306287
[No Abstract] [Full Text] [Related]
20. Accumulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultured cerebellar astrocytes.
Marini AM; Lipsky RH; Schwartz JP; Kopin IJ
J Neurochem; 1992 Apr; 58(4):1250-8. PubMed ID: 1548462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
